|
Authored by James Creelman
Content Type: Interviews
|
|
Summary
This interview features Lawrence Ganti, Corporate Director, Office of Strategy Management, for the Geneva, Switzerland based Serono, which reported 2005 revenues of more than $2.5 billion, making it the largest biotechnology company in Europe and among the leaders in the world. It has eight manufacturing plants and 4,900 employees spread across 45 countries. Serono’s groundbreaking work includes its treatments for infertility, growth hormone deficiency and multiple sclerosis. Serono was inducted into the prestigious Balanced Scorecard Collaborative Hall of Fame in 2006.
In this interview, drawing from his experience of facilitating the Balanced Scorecard program in Serono, Lawrence Ganti presents a practitioner’s viewpoint regarding various aspects of the Balanced Scorecard concept.
|
|
Read more...
|